Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK42360-Na Combined With Cetuximab With or Without Chemotherapy in BRAF V600-Mutant Metastatic Colorectal Cancer
NCT07790510Phase 2Recruiting
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Aug 2026
- Primary completion
- Sep 2029
- Countries
- 1
01
Overview
A Phase 2 trial of HSK42360-Na in colorectal cancer (CRC), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started Aug 2026; status: recruiting.
02
Drugs
HSK42360-Na
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07790510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07790510.